| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H3T6 kinase activity | 4.27e-05 | 2 | 131 | 2 | GO:0035403 | |
| GeneOntologyMolecularFunction | snoRNA binding | 7.04e-05 | 34 | 131 | 4 | GO:0030515 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SART3 NRIP1 RANBP2 ATR SF3A1 AFF3 YY2 TOPBP1 E2F7 XPC POLR1G TEP1 HNRNPU NUFIP1 ARID1B TET1 ACIN1 MLLT3 DDX21 SNRNP200 NIPBL SNRPN | 5.61e-05 | 1377 | 133 | 22 | GO:0140513 |
| GeneOntologyCellularComponent | nuclear body | RNF32 SART3 NRIP1 SDE2 RAD18 ATR SF3A1 AFF3 LARS1 TOPBP1 E2F7 PRX HNRNPU MKI67 ACIN1 ZFHX3 DUSP11 | 6.08e-05 | 903 | 133 | 17 | GO:0016604 |
| GeneOntologyCellularComponent | translation release factor complex | 1.20e-04 | 3 | 133 | 2 | GO:0018444 | |
| GeneOntologyCellularComponent | ASAP complex | 2.39e-04 | 4 | 133 | 2 | GO:0061574 | |
| GeneOntologyCellularComponent | fibrillar center | 4.93e-04 | 156 | 133 | 6 | GO:0001650 | |
| GeneOntologyCellularComponent | cytoplasmic region | 5.04e-04 | 360 | 133 | 9 | GO:0099568 | |
| GeneOntologyCellularComponent | microtubule organizing center | DLG5 RAD18 DZIP1L CD2AP TOPBP1 TEX9 HNRNPU SPATC1 TTLL6 DYNC2LI1 PRKCA PRKCB CFAP70 PIBF1 CSPP1 | 7.61e-04 | 919 | 133 | 15 | GO:0005815 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | 9.74e-04 | 317 | 133 | 8 | GO:0032838 | |
| Domain | PP1_bind | 4.88e-05 | 2 | 131 | 2 | PF15276 | |
| Domain | PP1-bd | 4.88e-05 | 2 | 131 | 2 | IPR029334 | |
| Domain | FAM21 | 4.88e-05 | 2 | 131 | 2 | IPR027308 | |
| Domain | Protein_kinase_C_a/b/g | 1.46e-04 | 3 | 131 | 2 | IPR014375 | |
| Domain | CAP-ZIP_m | 1.46e-04 | 3 | 131 | 2 | PF15255 | |
| Domain | FAM21/CAPZIP | 1.46e-04 | 3 | 131 | 2 | IPR029341 | |
| Domain | - | 4.09e-04 | 21 | 131 | 3 | 1.10.720.30 | |
| Domain | SAP | 4.71e-04 | 22 | 131 | 3 | PF02037 | |
| Domain | Cyt_P450_E_grp-II | 4.82e-04 | 5 | 131 | 2 | IPR002402 | |
| Domain | SAP | 5.39e-04 | 23 | 131 | 3 | SM00513 | |
| Domain | - | 6.20e-04 | 148 | 131 | 6 | 2.60.40.150 | |
| Domain | SAP | 6.93e-04 | 25 | 131 | 3 | PS50800 | |
| Domain | SAP_dom | 6.93e-04 | 25 | 131 | 3 | IPR003034 | |
| Domain | Cyt_P450_E_CYP3A | 7.19e-04 | 6 | 131 | 2 | IPR008072 | |
| Domain | SURP | 7.19e-04 | 6 | 131 | 2 | PS50128 | |
| Domain | Surp | 7.19e-04 | 6 | 131 | 2 | PF01805 | |
| Domain | SWAP | 7.19e-04 | 6 | 131 | 2 | SM00648 | |
| Domain | FAT | 7.19e-04 | 6 | 131 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 7.19e-04 | 6 | 131 | 2 | IPR003151 | |
| Domain | Surp | 7.19e-04 | 6 | 131 | 2 | IPR000061 | |
| Domain | C2_dom | 1.06e-03 | 164 | 131 | 6 | IPR000008 | |
| Domain | TPR-like_helical_dom | 1.30e-03 | 233 | 131 | 7 | IPR011990 | |
| Domain | RPR | 1.33e-03 | 8 | 131 | 2 | SM00582 | |
| Domain | CID_dom | 1.33e-03 | 8 | 131 | 2 | IPR006569 | |
| Domain | CID | 1.33e-03 | 8 | 131 | 2 | PS51391 | |
| Domain | DEAD/DEAH_box_helicase_dom | 1.73e-03 | 73 | 131 | 4 | IPR011545 | |
| Domain | DEAD | 1.73e-03 | 73 | 131 | 4 | PF00270 | |
| Domain | HAT | 2.12e-03 | 10 | 131 | 2 | SM00386 | |
| Domain | HAT | 2.12e-03 | 10 | 131 | 2 | IPR003107 | |
| Domain | C2 | 2.31e-03 | 131 | 131 | 5 | PF00168 | |
| Domain | C2 | 2.81e-03 | 137 | 131 | 5 | SM00239 | |
| Domain | C2 | 3.28e-03 | 142 | 131 | 5 | PS50004 | |
| Domain | - | 3.42e-03 | 207 | 131 | 6 | 1.25.40.10 | |
| Domain | - | 4.83e-03 | 15 | 131 | 2 | 1.10.150.60 | |
| Domain | BRIGHT | 4.83e-03 | 15 | 131 | 2 | SM00501 | |
| Domain | ARID_dom | 4.83e-03 | 15 | 131 | 2 | IPR001606 | |
| Domain | ARID | 4.83e-03 | 15 | 131 | 2 | PS51011 | |
| Domain | ARID | 4.83e-03 | 15 | 131 | 2 | PF01388 | |
| Domain | TPR_8 | 6.12e-03 | 53 | 131 | 3 | PF13181 | |
| Domain | - | DLG5 NWD1 DDX60 TEP1 DNAH7 HNRNPU GSPT2 UTP25 DYNC2LI1 DDX60L DDX21 SNRNP200 | 6.26e-03 | 746 | 131 | 12 | 3.40.50.300 |
| Domain | Helicase_C | 6.84e-03 | 107 | 131 | 4 | PF00271 | |
| Domain | HELICc | 6.84e-03 | 107 | 131 | 4 | SM00490 | |
| Domain | Lig_chan-Glu_bd | 6.94e-03 | 18 | 131 | 2 | PF10613 | |
| Domain | Glu/Gly-bd | 6.94e-03 | 18 | 131 | 2 | IPR019594 | |
| Domain | Lig_chan-Glu_bd | 6.94e-03 | 18 | 131 | 2 | SM00918 | |
| Domain | Iontro_rcpt | 6.94e-03 | 18 | 131 | 2 | IPR001320 | |
| Domain | Iono_rcpt_met | 6.94e-03 | 18 | 131 | 2 | IPR001508 | |
| Domain | Lig_chan | 6.94e-03 | 18 | 131 | 2 | PF00060 | |
| Domain | PBPe | 6.94e-03 | 18 | 131 | 2 | SM00079 | |
| Pathway | REACTOME_MRNA_SPLICING | 4.97e-05 | 201 | 92 | 8 | MM15411 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | RANBP2 SDE2 TUT4 SF3A1 U2SURP ETF1 HNRNPU GSPT2 UTP25 RBM7 ACIN1 PRKCA DDX21 SNRNP200 SNRPN | 6.43e-05 | 724 | 92 | 15 | M16843 |
| Pathway | REACTOME_MRNA_SPLICING | 7.23e-05 | 212 | 92 | 8 | M14033 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 8.02e-05 | 277 | 92 | 9 | MM15414 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 9.44e-05 | 283 | 92 | 9 | M13087 | |
| Pathway | REACTOME_METABOLISM_OF_RNA | RANBP2 SDE2 SF3A1 U2SURP ETF1 HNRNPU GSPT2 UTP25 RBM7 ACIN1 DDX21 SNRNP200 SNRPN | 1.63e-04 | 612 | 92 | 13 | MM15547 |
| Pathway | REACTOME_TRAFFICKING_OF_GLUR2_CONTAINING_AMPA_RECEPTORS | 1.71e-04 | 17 | 92 | 3 | M5488 | |
| Pathway | BIOCARTA_ION_PATHWAY | 4.16e-04 | 5 | 92 | 2 | MM1574 | |
| Pathway | BIOCARTA_PLCD_PATHWAY | 4.16e-04 | 5 | 92 | 2 | MM1587 | |
| Pathway | BIOCARTA_ION_PATHWAY | 4.16e-04 | 5 | 92 | 2 | M22059 | |
| Pathway | BIOCARTA_PLCD_PATHWAY | 4.16e-04 | 5 | 92 | 2 | M22080 | |
| Pathway | REACTOME_DISINHIBITION_OF_SNARE_FORMATION | 4.16e-04 | 5 | 92 | 2 | M26920 | |
| Pathway | REACTOME_CYTOSOLIC_TRNA_AMINOACYLATION | 4.93e-04 | 24 | 92 | 3 | M6591 | |
| Pathway | REACTOME_EUKARYOTIC_TRANSLATION_TERMINATION | 6.21e-04 | 6 | 92 | 2 | MM15419 | |
| Pathway | PID_VEGFR1_PATHWAY | 6.27e-04 | 26 | 92 | 3 | M226 | |
| Pathway | WP_MRNA_PROCESSING | SART3 RBM45 SF3A1 U2SURP HNRNPU NUFIP1 RBM7 ACIN1 DDX21 SNRPN | 7.03e-04 | 451 | 92 | 10 | MM15946 |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 8.66e-04 | 7 | 92 | 2 | MM1563 | |
| Pathway | BIOCARTA_PKC_PATHWAY | 8.66e-04 | 7 | 92 | 2 | MM1572 | |
| Pathway | BIOCARTA_ERBB4_PATHWAY | 8.66e-04 | 7 | 92 | 2 | M22043 | |
| Pathway | BIOCARTA_PKC_PATHWAY | 8.66e-04 | 7 | 92 | 2 | M22057 | |
| Pathway | REACTOME_TRAFFICKING_OF_AMPA_RECEPTORS | 1.06e-03 | 31 | 92 | 3 | M7223 | |
| Pathway | WP_NIPBL_ROLE_IN_DNA_DAMAGE_CORNELIA_DE_LANGE_SYNDROME | 1.15e-03 | 8 | 92 | 2 | M42528 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HCMV_US27_TO_CXCR4_GNB_G_PLCB_PKC_SIGNALING_PATHWAY | 1.15e-03 | 8 | 92 | 2 | M47555 | |
| Pathway | KEGG_MEDICUS_REFERENCE_TGFA_EGFR_PLCG_PKC_SIGNALING_PATHWAY | 1.15e-03 | 8 | 92 | 2 | M47479 | |
| Pathway | WP_PREGNANE_X_RECEPTOR_PATHWAY | 1.16e-03 | 32 | 92 | 3 | M39567 | |
| Pubmed | The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers. | SART3 RANBP2 RAD18 RSL1D1 SF3A1 U2SURP CD2AP YY2 TOPBP1 DIDO1 ZNF318 HNRNPU CDCA2 EEF1G ARID1B PRRC2C MKI67 RBM7 ACIN1 DDX21 SNRNP200 ATP5PD NIPBL SNRPN | 2.87e-13 | 954 | 134 | 24 | 36373674 |
| Pubmed | SART3 RANBP2 DENND4A ANK2 RSL1D1 PARP8 PCLO DZIP1L U2SURP GRIA2 XPC ZNF318 CEND1 PRX HNRNPU CDCA2 SPATC1 GSPT2 PRRC2C ACIN1 TMSB4X DDX21 ATP5PD NIPBL SNRPN ZNF292 | 4.60e-11 | 1442 | 134 | 26 | 35575683 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | SART3 RANBP2 SDE2 WASHC2C ANK2 RSL1D1 SF3A1 U2SURP ETF1 LARS1 DIDO1 ZNF318 PPA1 HNRNPU EEF1G PRRC2C MKI67 ACIN1 DDX21 SNRNP200 NIPBL | 8.17e-11 | 934 | 134 | 21 | 33916271 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RANBP2 RAD18 ATR RSL1D1 SF3A1 U2SURP TOPBP1 DIDO1 XPC ZNF318 POLR1G TTF1 HNRNPU RPRD1B CDCA2 MKI67 RBM7 ACIN1 DDX21 SNRNP200 ATP5PD NIPBL SNRPN | 9.27e-10 | 1294 | 134 | 23 | 30804502 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RANBP2 RAD18 WASHC2C ATR RSL1D1 SF3A1 DIDO1 XPC ZNF318 POLR1G RPRD1B MKI67 RBM7 ACIN1 ELK3 DDX21 SNRNP200 NIPBL | 1.22e-09 | 774 | 134 | 18 | 15302935 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | SART3 RANBP2 RAD18 WASHC2C RSL1D1 SF3A1 STK26 U2SURP CD2AP TOPBP1 XPC WASHC2A HNRNPU FAM83B NUFIP1 ARID1B MKI67 PIBF1 DDX21 SNRNP200 NIPBL | 3.66e-09 | 1155 | 134 | 21 | 20360068 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | SART3 RANBP2 DENND4A ATR RSL1D1 ACAD9 SF3A1 PCLO U2SURP ETF1 LARS1 PPA1 HNRNPU RPRD1B CDCA2 EEF1G MKI67 ACIN1 LMAN2 HARS1 DDX21 SNRNP200 NIPBL | 5.74e-09 | 1425 | 134 | 23 | 30948266 |
| Pubmed | SART3 RANBP2 RSL1D1 SF3A1 U2SURP DIDO1 ZNF318 TTF1 UTP25 PRRC2C MKI67 ACIN1 DDX21 SNRNP200 NIPBL | 3.78e-08 | 653 | 134 | 15 | 22586326 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | RANBP2 RSL1D1 SF3A1 U2SURP ETF1 DIDO1 PPA1 POLR1G HNRNPU RPRD1B CDCA2 EEF1G UTP25 MKI67 ACIN1 DDX21 SNRNP200 SNRPN | 5.25e-08 | 989 | 134 | 18 | 36424410 |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RANBP2 RAD18 ATR RBM45 SF3A1 U2SURP TRUB1 HNRNPU RBM7 ACIN1 DEPDC7 DDX21 SNRNP200 NIPBL | 6.29e-08 | 582 | 134 | 14 | 20467437 |
| Pubmed | RANBP2 RAD18 WASHC2C RSL1D1 TOPBP1 DIDO1 PLEKHA6 POLR1G MKI67 RBM7 ACIN1 PRKCA NIPBL | 8.38e-08 | 503 | 134 | 13 | 16964243 | |
| Pubmed | Unbiased Identification of trans Regulators of ADAR and A-to-I RNA Editing. | SART3 RANBP2 ANK2 SF3A1 U2SURP DIDO1 ZNF318 MKI67 ACIN1 DDX21 | 1.09e-07 | 271 | 134 | 10 | 32433965 |
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | RANBP2 SF3A1 YY2 TOPBP1 DIDO1 ZNF318 HNRNPU CDCA2 EEF1G MKI67 SNRNP200 | 1.53e-07 | 357 | 134 | 11 | 37059091 |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | SART3 SF3A1 DIDO1 ZNF318 MKI67 ACIN1 ZFHX3 DDX21 SNRNP200 SNRPN | 1.63e-07 | 283 | 134 | 10 | 30585729 |
| Pubmed | SART3 RANBP2 RSL1D1 U2SURP LARS1 HNRNPU FAM83B EEF1G PRRC2C MKI67 ACIN1 DDX21 SNRNP200 SNRPN | 2.64e-07 | 655 | 134 | 14 | 35819319 | |
| Pubmed | SART3 DLG5 ANK2 RBM45 RSL1D1 SF3A1 DIDO1 XPC TRUB1 TTF1 EEF1G PRRC2C MKI67 RBM7 ACIN1 FLRT3 HARS1 DDX21 CA3 DUSP11 | 3.20e-07 | 1371 | 134 | 20 | 36244648 | |
| Pubmed | SART3 GPRASP1 RANBP2 TUT4 WASHC2C ANK2 PCLO U2SURP GRIA2 CEND1 WASHC2A HNRNPU EEF1G GSPT2 PRRC2C PRKCA PRKCB ATP5PD | 4.20e-07 | 1139 | 134 | 18 | 36417873 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANBP2 RSL1D1 SF3A1 U2SURP LARS1 ZNF318 HNRNPU FAM83B EEF1G MKI67 ACIN1 PRKCA LMAN2 DDX21 SNRNP200 ATP5PD NIPBL | 4.60e-07 | 1024 | 134 | 17 | 24711643 |
| Pubmed | 4.82e-07 | 17 | 134 | 4 | 37072811 | ||
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | 5.27e-07 | 123 | 134 | 7 | 26912792 | |
| Pubmed | Characterization of the DOT1L network: implications of diverse roles for DOT1L. | 5.28e-07 | 41 | 134 | 5 | 20431927 | |
| Pubmed | The mRNA-bound proteome and its global occupancy profile on protein-coding transcripts. | SART3 TUT4 RBM45 RSL1D1 SF3A1 U2SURP DIDO1 HNRNPU GSPT2 PRRC2C RBM7 ACIN1 DDX21 SNRNP200 DUSP11 | 5.67e-07 | 807 | 134 | 15 | 22681889 |
| Pubmed | RANBP2 ETF1 LARS1 PPA1 HNRNPU EEF1G PRRC2C MKI67 DDX21 SNRNP200 | 6.66e-07 | 330 | 134 | 10 | 32529326 | |
| Pubmed | SART3 SF3A1 U2SURP LARS1 ZNF318 PPA1 WASHC2A EEF1G MKI67 ACIN1 DDX21 SNRNP200 | 6.69e-07 | 506 | 134 | 12 | 30890647 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | RANBP2 WASHC2C SF3A1 LARS1 DIDO1 HNRNPU EEF1G ACIN1 SNRNP200 NIPBL | 7.03e-07 | 332 | 134 | 10 | 32786267 |
| Pubmed | SARS-CoV-2 uses Spike glycoprotein to control the host's anaerobic metabolism by inhibiting LDHB. | RANBP2 RSL1D1 SF3A1 U2SURP ETF1 LARS1 PPA1 RPRD1B UTP25 PRRC2C ACIN1 SNRNP200 ATP5PD | 7.06e-07 | 607 | 134 | 13 | 39147351 |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | NRIP1 RANBP2 RSL1D1 SF3A1 U2SURP ETF1 LARS1 DIDO1 PPA1 POLR1G TTF1 HNRNPU EEF1G MKI67 ACIN1 PRKCB DDX21 SNRNP200 NIPBL | 7.76e-07 | 1318 | 134 | 19 | 30463901 |
| Pubmed | m6A regulation of cortical and retinal neurogenesis is mediated by the redundant m6A readers YTHDFs. | 7.81e-07 | 19 | 134 | 4 | 36039295 | |
| Pubmed | SART3 RANBP2 ACAD9 U2SURP HNRNPU RPRD1B MKI67 DDX21 SNRNP200 NIPBL | 8.73e-07 | 340 | 134 | 10 | 29478914 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | KDM5B DLG5 RANBP2 RBM45 SF3A1 U2SURP DIDO1 XPC HNRNPU EEF1G ARID1B RBM7 ACIN1 DDX21 SNRNP200 NIPBL ZNF292 | 9.79e-07 | 1082 | 134 | 17 | 38697112 |
| Pubmed | RAD18 WASHC2C RSL1D1 ACAD9 DZIP1L CD2AP PHTF2 DIDO1 ZNF318 WASHC2A SPATA1 RPRD1B ARID1B TET1 ACIN1 LMAN2 DDX21 | 1.00e-06 | 1084 | 134 | 17 | 11544199 | |
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | SART3 RSL1D1 SF3A1 U2SURP ETF1 LARS1 TOPBP1 HNRNPU EEF1G PRRC2C HARS1 DDX21 SNRNP200 ATP5PD NIPBL | 1.03e-06 | 847 | 134 | 15 | 35235311 |
| Pubmed | Binding of USP4 to cortactin enhances cell migration in HCT116 human colon cancer cells. | 1.09e-06 | 137 | 134 | 7 | 37039823 | |
| Pubmed | Phosphorylation of histone H3T6 by PKCbeta(I) controls demethylation at histone H3K4. | 1.11e-06 | 6 | 134 | 3 | 20228790 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | SART3 RANBP2 RSL1D1 U2SURP LARS1 XPC PPA1 POLR1G HNRNPU CDCA2 EEF1G MKI67 RBM7 ACIN1 PRKCA DDX60L DDX21 SNRNP200 NIPBL | 1.14e-06 | 1353 | 134 | 19 | 29467282 |
| Pubmed | 1.19e-06 | 272 | 134 | 9 | 31010829 | ||
| Pubmed | Identification of host proteins required for HIV infection through a functional genomic screen. | 1.19e-06 | 272 | 134 | 9 | 18187620 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KDM5B DLG5 DENND4A PARP8 CD2AP DYRK4 DNAH7 FAM83B CDCA2 VPS13D PRRC2C TET1 RBM7 PIBF1 CSPP1 | 1.27e-06 | 861 | 134 | 15 | 36931259 |
| Pubmed | WASHC2C SF3A1 U2SURP LARS1 PPA1 TRUB1 HNRNPU RPRD1B EEF1G MKI67 TMSB4X SNRNP200 | 1.27e-06 | 538 | 134 | 12 | 28524877 | |
| Pubmed | RANBP2 RSL1D1 SF3A1 U2SURP ETF1 LARS1 DIDO1 ZNF318 PPA1 HNRNPU EEF1G ARID1B PRRC2C MKI67 SNRNP200 NIPBL ZNF292 | 1.27e-06 | 1103 | 134 | 17 | 34189442 | |
| Pubmed | SART3 RANBP2 RSL1D1 U2SURP LARS1 HNRNPU EEF1G PRRC2C MKI67 ACIN1 DDX21 SNRNP200 SNRPN | 1.29e-06 | 641 | 134 | 13 | 36057605 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | RSL1D1 LARS1 TOPBP1 DIDO1 POLR1G TTF1 HNRNPU NUFIP1 CDCA2 PRRC2C MKI67 ACIN1 DDX21 SNRNP200 | 1.51e-06 | 759 | 134 | 14 | 35915203 |
| Pubmed | 1.68e-06 | 210 | 134 | 8 | 16565220 | ||
| Pubmed | HIV-1 Vpr induces cell cycle arrest and enhances viral gene expression by depleting CCDC137. | 1.83e-06 | 148 | 134 | 7 | 32538781 | |
| Pubmed | 1.92e-06 | 149 | 134 | 7 | 25184681 | ||
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | SART3 RANBP2 RSL1D1 SF3A1 U2SURP ETF1 LARS1 DIDO1 PPA1 LRRC8D HNRNPU EEF1G GSPT2 PRRC2C DDX21 SNRNP200 ATP5PD NIPBL SNRPN | 2.21e-06 | 1415 | 134 | 19 | 28515276 |
| Pubmed | 2.37e-06 | 220 | 134 | 8 | 24550385 | ||
| Pubmed | TRIM33 drives prostate tumor growth by stabilizing androgen receptor from Skp2-mediated degradation. | 2.37e-06 | 220 | 134 | 8 | 35785414 | |
| Pubmed | 3.09e-06 | 8 | 134 | 3 | 33594090 | ||
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | SART3 RANBP2 U2SURP CD2AP LARS1 DIDO1 XPC RPRD1B DDX21 SNRPN | 3.26e-06 | 394 | 134 | 10 | 27248496 |
| Pubmed | DLG5 RANBP2 ANK2 SF3A1 CD2AP ETF1 LARS1 HNRNPU FAM83B EEF1G PRRC2C LMAN2 SNRNP200 | 3.83e-06 | 708 | 134 | 13 | 39231216 | |
| Pubmed | 4.62e-06 | 9 | 134 | 3 | 23901102 | ||
| Pubmed | SART3 TUT4 RSL1D1 TOPBP1 HNRNPU RPRD1B EEF1G GSPT2 UTP25 DYNC2LI1 RBM7 DDX21 SNRPN | 4.80e-06 | 723 | 134 | 13 | 34133714 | |
| Pubmed | SART3 DLG5 RANBP2 ACAD9 CD2AP TOPBP1 DIDO1 XPC ZNF318 POLR1G TTF1 FAM83B EEF1G UTP25 RBM7 ZFHX3 ATP5PD NIPBL DUSP11 | 4.98e-06 | 1497 | 134 | 19 | 31527615 | |
| Pubmed | 5.10e-06 | 244 | 134 | 8 | 29884807 | ||
| Pubmed | RANBP2 WASHC2C RSL1D1 SF3A1 U2SURP XPC POLR1G HNRNPU MKI67 RBM7 ACIN1 DDX21 SNRNP200 SNRPN | 5.34e-06 | 847 | 134 | 14 | 35850772 | |
| Pubmed | DLG5 RANBP2 SF3A1 STK26 U2SURP ETF1 LARS1 PPA1 PLEKHA6 HNRNPU FAM83B EEF1G GSPT2 MKI67 ACIN1 MLLT3 DDX21 | 6.51e-06 | 1247 | 134 | 17 | 27684187 | |
| Pubmed | RSL1D1 ACAD9 DDX60 ETF1 XPC POLR1G FAM83B ARID1B MKI67 ACIN1 LMAN2 DDX21 | 6.78e-06 | 634 | 134 | 12 | 34591612 | |
| Pubmed | 6.97e-06 | 32 | 134 | 4 | 14613977 | ||
| Pubmed | The PHLPP1 N-Terminal Extension Is a Mitotic Cdk1 Substrate and Controls an Interactome Switch. | 7.24e-06 | 256 | 134 | 8 | 33397691 | |
| Pubmed | 7.33e-06 | 340 | 134 | 9 | 24332808 | ||
| Pubmed | The DNA sequence and comparative analysis of human chromosome 10. | 8.24e-06 | 345 | 134 | 9 | 15164054 | |
| Pubmed | 9.02e-06 | 11 | 134 | 3 | 37172586 | ||
| Pubmed | KSHV episome tethering sites on host chromosomes and regulation of latency-lytic switch by CHD4. | 1.18e-05 | 130 | 134 | 6 | 35545047 | |
| Pubmed | 1.18e-05 | 130 | 134 | 6 | 12421765 | ||
| Pubmed | RANBP2 CLGN LARS1 PPA1 HNRNPU EEF1G MKI67 DDX21 SNRNP200 ATP5PD | 1.33e-05 | 463 | 134 | 10 | 34901782 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 26660275 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 28986474 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 16673150 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 16517978 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 21658591 | ||
| Pubmed | Antibody specific for phosphorylated AMPA-type glutamate receptors at GluR2 Ser-696. | 1.47e-05 | 2 | 134 | 2 | 8848293 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 29307535 | ||
| Pubmed | Genes encoding catalytic subunits of protein kinase A and risk of spina bifida. | 1.47e-05 | 2 | 134 | 2 | 16080189 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 26772622 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 31525436 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 26538089 | ||
| Pubmed | Unravelling the different functions of protein kinase C isoforms in platelets. | 1.47e-05 | 2 | 134 | 2 | 21596041 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 25616575 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 20827171 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 25916852 | ||
| Pubmed | FAM21 is critical for TLR2/CLEC4E-mediated dendritic cell function against Candida albicans. | 1.47e-05 | 2 | 134 | 2 | 36717248 | |
| Pubmed | Adenovirus 12 E4orf6 inhibits ATR activation by promoting TOPBP1 degradation. | 1.47e-05 | 2 | 134 | 2 | 20566845 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 38073330 | ||
| Pubmed | Expression of CYP3A4 and CYP3A7 in Human Foetal Tissues and its Correlation with Nuclear Receptors. | 1.47e-05 | 2 | 134 | 2 | 25689036 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 17455194 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 27349315 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 21323641 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 11007883 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 23035091 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 9486851 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 16430878 | ||
| Pubmed | Suppression of PKC causes oncogenic stress for triggering apoptosis in cancer cells. | 1.47e-05 | 2 | 134 | 2 | 28415683 | |
| Pubmed | PP1/Repo-man dephosphorylates mitotic histone H3 at T3 and regulates chromosomal aurora B targeting. | 1.47e-05 | 2 | 134 | 2 | 21514157 | |
| Pubmed | cPKC-dependent sequestration of membrane-recycling components in a subset of recycling endosomes. | 1.47e-05 | 2 | 134 | 2 | 14527960 | |
| Pubmed | TopBP1 assembles nuclear condensates to switch on ATR signaling. | 1.47e-05 | 2 | 134 | 2 | 33503405 | |
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 14718568 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 25693686 | ||
| Pubmed | 1.47e-05 | 2 | 134 | 2 | 11466413 | ||
| Pubmed | Differential regulation of CYP3A4 and CYP3A7 by dimethylsulfoxide in primary human hepatocytes. | 1.47e-05 | 2 | 134 | 2 | 15379787 | |
| Interaction | SMC5 interactions | SART3 RANBP2 RAD18 RSL1D1 SF3A1 U2SURP CD2AP YY2 TOPBP1 DIDO1 ZNF318 HNRNPU CDCA2 EEF1G ARID1B PRRC2C MKI67 RBM7 ACIN1 DDX21 SNRNP200 ATP5PD NIPBL SNRPN | 3.05e-08 | 1000 | 132 | 24 | int:SMC5 |
| Interaction | NAA40 interactions | SART3 RANBP2 SDE2 WASHC2C ANK2 RSL1D1 SF3A1 U2SURP ETF1 LARS1 DIDO1 XPC ZNF318 PPA1 HNRNPU EEF1G PRRC2C MKI67 ACIN1 DDX21 SNRNP200 NIPBL | 3.77e-07 | 978 | 132 | 22 | int:NAA40 |
| Interaction | NUP43 interactions | RANBP2 RSL1D1 DDX60 TOPBP1 CCDC168 XPC ZNF318 TTF1 CDCA2 ARID1B PRRC2C MKI67 ACIN1 ZFHX3 SNRNP200 NIPBL ZNF292 | 7.16e-07 | 625 | 132 | 17 | int:NUP43 |
| Interaction | KPNA3 interactions | NRIP1 RANBP2 CLGN RSL1D1 ETF1 POLR1G HNRNPU EEF1G ACIN1 DDX21 SNRNP200 | 7.33e-07 | 248 | 132 | 11 | int:KPNA3 |
| Interaction | CIT interactions | GPRASP1 NRIP1 RANBP2 CLGN RSL1D1 DDX60 SF3A1 PCLO DIDO1 PPA1 PLEKHA6 POLR1G HNRNPU RPRD1B EEF1G PRRC2C MKI67 ACIN1 DDX60L HARS1 PIBF1 DDX21 CSPP1 SNRNP200 ATP5PD NIPBL | 2.19e-06 | 1450 | 132 | 26 | int:CIT |
| Interaction | LINC00240 interactions | 3.01e-06 | 16 | 132 | 4 | int:LINC00240 | |
| Interaction | SNRPA interactions | SART3 RAD18 SF3A1 DIDO1 ZNF318 IFIT2 HNRNPU RPRD1B PRRC2C RBM7 ACIN1 DDX21 SNRNP200 SNRPN | 3.46e-06 | 482 | 132 | 14 | int:SNRPA |
| Interaction | ACTC1 interactions | SART3 RBM45 SF3A1 U2SURP CD2AP LARS1 ZNF318 PPA1 WASHC2A EEF1G ARID1B MKI67 ACIN1 TMSB4X DDX21 SNRNP200 | 1.27e-05 | 694 | 132 | 16 | int:ACTC1 |
| Interaction | H2BC21 interactions | SART3 KDM5B PCLO DIDO1 XPC TTF1 HNRNPU RPRD1B ARID1B SASH3 TET1 MKI67 PRKCB DDX60L NIPBL ZNF292 | 1.31e-05 | 696 | 132 | 16 | int:H2BC21 |
| Interaction | H3C1 interactions | RAD18 ANK2 RSL1D1 U2SURP DIDO1 XPC POLR1G HNRNPU CDCA2 USP38 PRRC2C MKI67 PRKCA PRKCB MLLT3 ZFHX3 NIPBL ZNF292 | 2.42e-05 | 901 | 132 | 18 | int:H3C1 |
| Interaction | CCDC8 interactions | RANBP2 AFF3 LARS1 ZNF318 HNRNPU FAM83B EEF1G PTPRN2 MKI67 PRKCA LMAN2 DDX21 SNRNP200 ATP5PD NIPBL | 2.65e-05 | 656 | 132 | 15 | int:CCDC8 |
| Interaction | SNRPA1 interactions | RANBP2 RAD18 SF3A1 U2SURP IFIT2 HNRNPU EEF1G ACIN1 SNRNP200 SNRPN | 2.90e-05 | 300 | 132 | 10 | int:SNRPA1 |
| Interaction | SIRT7 interactions | SART3 RANBP2 ATR RSL1D1 SF3A1 U2SURP DIDO1 ZNF318 TTF1 UTP25 PRRC2C MKI67 ACIN1 DDX21 SNRNP200 NIPBL | 2.96e-05 | 744 | 132 | 16 | int:SIRT7 |
| Interaction | SUMO2 interactions | RANBP2 WASHC2C SF3A1 LARS1 DIDO1 HNRNPU RPRD1B EEF1G MKI67 ACIN1 ELK3 DDX21 SNRNP200 NIPBL | 3.41e-05 | 591 | 132 | 14 | int:SUMO2 |
| Interaction | THRAP3 interactions | SART3 RAD18 RBM45 SF3A1 PCLO HNRNPU EEF1G GSPT2 ACIN1 DDX21 SNRNP200 NIPBL | 3.54e-05 | 443 | 132 | 12 | int:THRAP3 |
| Interaction | MIRLET7C interactions | 4.27e-05 | 97 | 132 | 6 | int:MIRLET7C | |
| Interaction | SNRPF interactions | SART3 SF3A1 U2SURP DIDO1 IFIT2 HNRNPU RPRD1B ACIN1 DDX21 SNRNP200 SNRPN | 4.71e-05 | 385 | 132 | 11 | int:SNRPF |
| Interaction | CTNNBL1 interactions | 4.73e-05 | 197 | 132 | 8 | int:CTNNBL1 | |
| Interaction | RNF113A interactions | SART3 RANBP2 RSL1D1 U2SURP LARS1 POLR1G HNRNPU FAM83B EEF1G PRRC2C MKI67 ACIN1 DDX21 SNRNP200 SNRPN | 4.88e-05 | 692 | 132 | 15 | int:RNF113A |
| Interaction | MIRLET7D interactions | 5.37e-05 | 101 | 132 | 6 | int:MIRLET7D | |
| Interaction | GSK3A interactions | DLG5 DENND4A SF3A1 PARP8 U2SURP WASHC2A HNRNPU EEF1G VPS13D ACIN1 PRKCA PRKCB | 5.54e-05 | 464 | 132 | 12 | int:GSK3A |
| Interaction | CHL1 interactions | 5.79e-05 | 12 | 132 | 3 | int:CHL1 | |
| Interaction | TERF2IP interactions | SDE2 RAD18 U2SURP TOPBP1 DIDO1 ZNF318 PRX HNRNPU RPRD1B CDCA2 MKI67 NIPBL ZNF292 | 6.98e-05 | 552 | 132 | 13 | int:TERF2IP |
| Interaction | SNRNP40 interactions | RAD18 RSL1D1 SF3A1 XPC ZNF318 NUFIP1 CDCA2 ARID1B MKI67 ACIN1 ZFHX3 DDX21 SNRNP200 SNRPN | 7.62e-05 | 637 | 132 | 14 | int:SNRNP40 |
| Interaction | DDX23 interactions | RAD18 RSL1D1 SF3A1 STK26 U2SURP XPC HNRNPU EEF1G ACIN1 DDX21 SNRNP200 SNRPN | 7.65e-05 | 480 | 132 | 12 | int:DDX23 |
| Interaction | MIR34B interactions | 8.64e-05 | 110 | 132 | 6 | int:MIR34B | |
| Interaction | PCDHA2 interactions | 9.48e-05 | 14 | 132 | 3 | int:PCDHA2 | |
| Interaction | SF3B1 interactions | SART3 NRIP1 RANBP2 RSL1D1 SF3A1 U2SURP HNRNPU RBM7 ACIN1 DDX21 SNRNP200 NIPBL SNRPN | 9.81e-05 | 571 | 132 | 13 | int:SF3B1 |
| Interaction | SLX4 interactions | RANBP2 SF3A1 AFF3 YY2 TOPBP1 DIDO1 ZNF318 HNRNPU CDCA2 EEF1G MKI67 SNRNP200 NIPBL | 9.98e-05 | 572 | 132 | 13 | int:SLX4 |
| Interaction | NPM1 interactions | SART3 RAD18 ATR RBM45 RSL1D1 DIDO1 GRIA2 XPC PPA1 POLR1G TTF1 HNRNPU EEF1G CFAP54 PRRC2C MKI67 PRKCA DDX21 SNRNP200 DUSP11 | 1.07e-04 | 1201 | 132 | 20 | int:NPM1 |
| Interaction | SNW1 interactions | RANBP2 RAD18 ATR RBM45 SF3A1 U2SURP TRUB1 HNRNPU EEF1G MKI67 ACIN1 HARS1 DEPDC7 SNRNP200 NIPBL | 1.15e-04 | 747 | 132 | 15 | int:SNW1 |
| Interaction | PPIH interactions | 1.16e-04 | 116 | 132 | 6 | int:PPIH | |
| Interaction | MIR18A interactions | 1.17e-04 | 73 | 132 | 5 | int:MIR18A | |
| Interaction | SNRPB interactions | SART3 SF3A1 U2SURP DIDO1 ZNF318 IFIT2 HNRNPU RPRD1B C16orf46 ACIN1 SNRNP200 SNRPN | 1.54e-04 | 517 | 132 | 12 | int:SNRPB |
| Interaction | SNRPC interactions | SF3A1 DIDO1 ZNF318 IFIT2 HNRNPU RPRD1B RBM7 ACIN1 DDX21 SNRNP200 SNRPN | 1.54e-04 | 440 | 132 | 11 | int:SNRPC |
| Interaction | BIRC3 interactions | SART3 RANBP2 DENND4A ATR RSL1D1 ACAD9 SF3A1 U2SURP ETF1 LARS1 PPA1 HNRNPU RPRD1B CDCA2 EEF1G MKI67 ACIN1 LMAN2 HARS1 DDX21 SNRNP200 | 1.55e-04 | 1334 | 132 | 21 | int:BIRC3 |
| Interaction | CEBPB interactions | RANBP2 RSL1D1 SF3A1 U2SURP ETF1 LARS1 XPC PPA1 POLR1G HNRNPU RPRD1B EEF1G KITLG PRRC2C MKI67 RBM7 ACIN1 MLLT3 HARS1 DDX21 SNRNP200 ZNF292 | 1.68e-04 | 1443 | 132 | 22 | int:CEBPB |
| Interaction | YWHAG interactions | KDM5B DLG5 DENND4A PARP8 DZIP1L CD2AP DNAH7 FAM83B CDCA2 EEF1G VPS13D PRRC2C TET1 RBM7 ACIN1 PRKCA PRKCB PIBF1 CSPP1 SNRNP200 | 1.79e-04 | 1248 | 132 | 20 | int:YWHAG |
| Interaction | RPA4 interactions | RANBP2 SDE2 SF3A1 U2SURP CD2AP XPC WASHC2A EEF1G PRRC2C MKI67 DDX21 | 1.94e-04 | 452 | 132 | 11 | int:RPA4 |
| Interaction | NDN interactions | RANBP2 ETF1 LARS1 PPA1 HNRNPU EEF1G PRRC2C MKI67 CFAP418 DDX21 SNRNP200 | 1.98e-04 | 453 | 132 | 11 | int:NDN |
| Interaction | CWF19L2 interactions | 1.99e-04 | 182 | 132 | 7 | int:CWF19L2 | |
| Interaction | SNRNP200 interactions | SART3 RANBP2 RBM45 SF3A1 HNRNPU EEF1G MKI67 DDX21 SNRNP200 NIPBL SNRPN | 2.26e-04 | 460 | 132 | 11 | int:SNRNP200 |
| Interaction | QPRT interactions | 2.28e-04 | 84 | 132 | 5 | int:QPRT | |
| Interaction | MYCN interactions | SART3 KDM5B SDE2 RSL1D1 SF3A1 U2SURP DIDO1 PPA1 PLEKHA6 POLR1G HNRNPU EEF1G ARID1B GSPT2 PRRC2C MKI67 RBM7 ACIN1 DDX21 SNRNP200 ATP5PD | 2.30e-04 | 1373 | 132 | 21 | int:MYCN |
| Interaction | SRRM2 interactions | RAD18 SF3A1 POLR1G WASHC2A HNRNPU GSPT2 PRRC2C RBM7 ACIN1 DDX21 SNRNP200 | 2.34e-04 | 462 | 132 | 11 | int:SRRM2 |
| Interaction | APOBEC3C interactions | 2.35e-04 | 187 | 132 | 7 | int:APOBEC3C | |
| Interaction | MIR18B interactions | 2.41e-04 | 85 | 132 | 5 | int:MIR18B | |
| Interaction | AR interactions | SART3 NRIP1 KDM5B U2SURP DIDO1 ZNF318 HNRNPU RPRD1B CDCA2 USP26 ARID1B SH2D1B ACIN1 ZFHX3 SNRNP200 NIPBL IL6ST | 2.64e-04 | 992 | 132 | 17 | int:AR |
| Interaction | DOT1L interactions | RANBP2 RBM45 RSL1D1 SF3A1 U2SURP XPC POLR1G HNRNPU MKI67 RBM7 ACIN1 MLLT3 DDX21 SNRNP200 SNRPN | 2.65e-04 | 807 | 132 | 15 | int:DOT1L |
| Interaction | LSM2 interactions | 2.67e-04 | 191 | 132 | 7 | int:LSM2 | |
| Interaction | MECP2 interactions | KDM5B DLG5 RANBP2 RBM45 SF3A1 U2SURP DIDO1 GRIA2 XPC POLR1G HNRNPU EEF1G ARID1B MKI67 RBM7 ACIN1 DDX21 SNRNP200 NIPBL ZNF292 | 2.68e-04 | 1287 | 132 | 20 | int:MECP2 |
| Interaction | DCPS interactions | SART3 RANBP2 ACAD9 U2SURP HNRNPU RPRD1B MKI67 DDX21 SNRNP200 NIPBL | 2.74e-04 | 394 | 132 | 10 | int:DCPS |
| Interaction | COIL interactions | SART3 RAD18 RSL1D1 SF3A1 XPC POLR1G MKI67 MLLT3 SNRNP200 NIPBL SNRPN ZNF292 | 2.80e-04 | 552 | 132 | 12 | int:COIL |
| Interaction | RRAD interactions | 2.89e-04 | 20 | 132 | 3 | int:RRAD | |
| Interaction | NR2C2 interactions | NRIP1 RANBP2 RSL1D1 SF3A1 U2SURP CD2AP ETF1 LARS1 DIDO1 PPA1 POLR1G TTF1 HNRNPU EEF1G MKI67 ACIN1 PRKCB ELK3 DDX21 SNRNP200 NIPBL | 3.08e-04 | 1403 | 132 | 21 | int:NR2C2 |
| Interaction | MIR221 interactions | 3.14e-04 | 90 | 132 | 5 | int:MIR221 | |
| Interaction | SLC25A41 interactions | 3.14e-04 | 90 | 132 | 5 | int:SLC25A41 | |
| Interaction | HSD17B7P2 interactions | 3.35e-04 | 21 | 132 | 3 | int:HSD17B7P2 | |
| Interaction | ETF1 interactions | 3.48e-04 | 142 | 132 | 6 | int:ETF1 | |
| Interaction | USP39 interactions | 3.64e-04 | 201 | 132 | 7 | int:USP39 | |
| Interaction | MIR19B2 interactions | 3.85e-04 | 94 | 132 | 5 | int:MIR19B2 | |
| Interaction | MIRLET7F1 interactions | 3.85e-04 | 94 | 132 | 5 | int:MIRLET7F1 | |
| Interaction | BAG5 interactions | 4.19e-04 | 341 | 132 | 9 | int:BAG5 | |
| Interaction | PRPF4 interactions | 4.22e-04 | 271 | 132 | 8 | int:PRPF4 | |
| Interaction | MIRLET7A2 interactions | 4.24e-04 | 96 | 132 | 5 | int:MIRLET7A2 | |
| Interaction | SNIP1 interactions | RAD18 ATR RSL1D1 SF3A1 HNRNPU ARID1B ACIN1 DDX21 SNRNP200 NIPBL | 4.28e-04 | 417 | 132 | 10 | int:SNIP1 |
| Interaction | CCDC97 interactions | 4.32e-04 | 54 | 132 | 4 | int:CCDC97 | |
| Interaction | MIRLET7F2 interactions | 4.45e-04 | 97 | 132 | 5 | int:MIRLET7F2 | |
| Interaction | MIR363 interactions | 4.45e-04 | 97 | 132 | 5 | int:MIR363 | |
| Interaction | EEF1A1 interactions | RANBP2 RAD18 RBM45 U2SURP LARS1 PPA1 HNRNPU EEF1G PRRC2C TMSB4X MLLT3 HARS1 SNRNP200 NIPBL | 4.80e-04 | 762 | 132 | 14 | int:EEF1A1 |
| Interaction | MIR128-2 interactions | 4.88e-04 | 99 | 132 | 5 | int:MIR128-2 | |
| Interaction | U2SURP interactions | 4.96e-04 | 349 | 132 | 9 | int:U2SURP | |
| Interaction | BRCA1 interactions | SART3 NRIP1 RAD18 ATR RBM45 RSL1D1 SF3A1 LARS1 TOPBP1 PPA1 HNRNPU RPRD1B NUFIP1 CDCA2 EEF1G MKI67 DDX21 SNRNP200 NIPBL | 5.03e-04 | 1249 | 132 | 19 | int:BRCA1 |
| Interaction | POLR1E interactions | 5.06e-04 | 350 | 132 | 9 | int:POLR1E | |
| Interaction | MIR25 interactions | 5.35e-04 | 101 | 132 | 5 | int:MIR25 | |
| Interaction | WASHC4 interactions | 5.60e-04 | 102 | 132 | 5 | int:WASHC4 | |
| Interaction | GSK3B interactions | DLG5 DENND4A GRIA2 PPA1 WASHC2A HNRNPU RPRD1B NUFIP1 EEF1G VPS13D PRRC2C MKI67 PRKCA PRKCB LMAN2 | 5.68e-04 | 868 | 132 | 15 | int:GSK3B |
| Interaction | SSRP1 interactions | RANBP2 RAD18 RSL1D1 DIDO1 XPC POLR1G HNRNPU RPRD1B ACIN1 DDX21 TXNDC2 SNRNP200 NIPBL | 5.69e-04 | 685 | 132 | 13 | int:SSRP1 |
| Interaction | CDK9 interactions | SART3 ATR SF3A1 STK26 AFF3 HNRNPU NUFIP1 PRRC2C ACIN1 MLLT3 DDX21 IL6ST ZMYM6 | 5.69e-04 | 685 | 132 | 13 | int:CDK9 |
| Interaction | MIR15B interactions | 5.85e-04 | 103 | 132 | 5 | int:MIR15B | |
| Interaction | MIR7-1 interactions | 5.85e-04 | 103 | 132 | 5 | int:MIR7-1 | |
| Interaction | RBM17 interactions | 5.92e-04 | 218 | 132 | 7 | int:RBM17 | |
| Interaction | ADAR interactions | 6.02e-04 | 286 | 132 | 8 | int:ADAR | |
| Interaction | MIR34A interactions | 6.12e-04 | 104 | 132 | 5 | int:MIR34A | |
| Interaction | PTGES3 interactions | RANBP2 CD2AP ETF1 TOPBP1 DYRK4 TEP1 UTP25 DDX60L SNRNP200 DUSP11 | 6.16e-04 | 437 | 132 | 10 | int:PTGES3 |
| Interaction | MIRLET7E interactions | 6.67e-04 | 106 | 132 | 5 | int:MIRLET7E | |
| Interaction | HNRNPDL interactions | 6.70e-04 | 364 | 132 | 9 | int:HNRNPDL | |
| Interaction | SUPT16H interactions | RANBP2 RAD18 RSL1D1 SF3A1 XPC POLR1G HNRNPU ACIN1 DDX21 TXNDC2 | 6.72e-04 | 442 | 132 | 10 | int:SUPT16H |
| Interaction | STAG2 interactions | 6.95e-04 | 224 | 132 | 7 | int:STAG2 | |
| Interaction | KPNA4 interactions | 7.13e-04 | 225 | 132 | 7 | int:KPNA4 | |
| Interaction | HECTD1 interactions | NRIP1 RSL1D1 U2SURP LARS1 TOPBP1 DIDO1 POLR1G TTF1 HNRNPU NUFIP1 CDCA2 PRRC2C MKI67 ACIN1 DDX21 SNRNP200 | 7.14e-04 | 984 | 132 | 16 | int:HECTD1 |
| Interaction | MIRLET7A1 interactions | 7.26e-04 | 108 | 132 | 5 | int:MIRLET7A1 | |
| GeneFamily | WASH complex | 3.39e-04 | 6 | 87 | 2 | 1331 | |
| GeneFamily | Cytochrome P450 family 3 | 6.29e-04 | 8 | 87 | 2 | 1002 | |
| GeneFamily | AF4/FMR2 family|Super elongation complex | 8.06e-04 | 9 | 87 | 2 | 1280 | |
| GeneFamily | C2 domain containing protein kinases | 1.00e-03 | 10 | 87 | 2 | 835 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 2.30e-03 | 115 | 87 | 4 | 769 | |
| GeneFamily | AT-rich interaction domain containing | 2.31e-03 | 15 | 87 | 2 | 418 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_3DY_DN | GPRASP1 RANBP2 SDE2 TUT4 SF3A1 PARP8 U2SURP RPRD1B MGAT5 DDX21 SNRNP200 IL6ST | 2.38e-06 | 432 | 134 | 12 | M41149 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | ATR RBM45 STK26 CD2AP TOPBP1 E2F7 HNRNPU KITLG MLLT3 HARS1 SNRNP200 DUSP11 | 2.49e-06 | 434 | 134 | 12 | M15150 |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_UP | ATR RBM45 STK26 CD2AP TOPBP1 E2F7 HNRNPU KITLG MLLT3 HARS1 SNRNP200 DUSP11 | 3.45e-06 | 448 | 134 | 12 | MM1044 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | NRIP1 KDM5B RANBP2 TUT4 ATR U2SURP CD2AP TOPBP1 MGAT5 PRRC2C PRKCA ZFHX3 PIBF1 DDX21 NIPBL ZNF292 | 8.14e-06 | 856 | 134 | 16 | M4500 |
| Coexpression | GSE23502_BM_VS_COLON_TUMOR_MYELOID_DERIVED_SUPPRESSOR_CELL_DN | 9.16e-06 | 200 | 134 | 8 | M8088 | |
| Coexpression | DODD_NASOPHARYNGEAL_CARCINOMA_UP | RANBP2 RAD18 ATR RSL1D1 DDX60 U2SURP LARS1 TOPBP1 PPA1 TRUB1 HNRNPU FAM83B MSR1 CDCA2 KITLG UTP25 PRRC2C TET1 MKI67 DDX60L DDX21 | 9.48e-06 | 1407 | 134 | 21 | M14427 |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | NRIP1 TUT4 ATR U2SURP CD2AP TOPBP1 MGAT5 PRRC2C PRKCA PIBF1 ZNF292 | 2.88e-05 | 466 | 134 | 11 | M13522 |
| Coexpression | GSE14415_FOXP3_KO_NATURAL_TREG_VS_TCONV_UP | 2.91e-05 | 171 | 134 | 7 | M2947 | |
| Coexpression | DESCARTES_MAIN_FETAL_CILIATED_EPITHELIAL_CELLS | RNF32 ENKUR NWD1 DZIP1L ARHGEF38 TEX9 DNAH7 C16orf46 CFAP54 TTLL6 CFAP70 CSPP1 CFAP99 | 4.66e-05 | 678 | 134 | 13 | M40124 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | GPRASP1 TUT4 ANK2 PCLO AFF3 GRIA2 GRID1 ZNF318 CEND1 PLEKHA6 MSR1 MGAT5 DNAJC12 PRKCA PRKCB MLLT3 ZFHX3 | 5.08e-05 | 1106 | 134 | 17 | M39071 |
| Coexpression | GSE17301_IFNA2_VS_IFNA5_STIM_ACD3_ACD28_ACT_CD8_TCELL_UP | 7.38e-05 | 198 | 134 | 7 | M8036 | |
| Coexpression | GSE29618_PRE_VS_DAY7_POST_LAIV_FLU_VACCINE_PDC_DN | 7.38e-05 | 198 | 134 | 7 | M5001 | |
| Coexpression | GSE11057_NAIVE_VS_EFF_MEMORY_CD4_TCELL_UP | 7.38e-05 | 198 | 134 | 7 | M3104 | |
| Coexpression | GSE20727_H2O2_VS_ROS_INHIBITOR_TREATED_DC_DN | 7.61e-05 | 199 | 134 | 7 | M9253 | |
| Coexpression | GSE32423_CTRL_VS_IL7_IL4_MEMORY_CD8_TCELL_UP | 7.86e-05 | 200 | 134 | 7 | M5087 | |
| Coexpression | GSE22935_UNSTIM_VS_48H_MBOVIS_BCG_STIM_MACROPHAGE_UP | 7.86e-05 | 200 | 134 | 7 | M7777 | |
| Coexpression | GSE360_L_DONOVANI_VS_L_MAJOR_MAC_UP | 7.86e-05 | 200 | 134 | 7 | M5231 | |
| Coexpression | NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_3DY_NEGATIVE | 1.08e-04 | 363 | 134 | 9 | M41103 | |
| Coexpression | DARWICHE_PAPILLOMA_PROGRESSION_RISK | 1.12e-04 | 92 | 134 | 5 | MM503 | |
| Coexpression | BERENJENO_TRANSFORMED_BY_RHOA_UP | RSL1D1 ETF1 TOPBP1 PHTF2 PPA1 IFIT2 RPRD1B MKI67 TMSB4X HARS1 DDX21 | 1.26e-04 | 550 | 134 | 11 | M16189 |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_top-relative-expression-ranked_1000 | RNF32 RAD18 ENKUR ATR LARS1 PHTF2 ZNF318 EPB41L4A SPATA1 CDCA2 USP26 EEF1G GSPT2 TET1 DEPDC7 DDX21 CSPP1 SNRPN ZMYM6 | 6.46e-07 | 810 | 132 | 19 | gudmap_dev gonad_e13.5_M_GermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | RNF32 PCLO U2SURP TEX9 LRRC8D CNTN6 HNRNPU FAM83B MSR1 TMTC1 GSPT2 KITLG PIBF1 NIPBL SNRPN PHF21B ATG16L2 CA3 ZNF292 | 1.13e-05 | 986 | 132 | 19 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 | RAD18 TUT4 ANK2 PARP8 E2F7 PHTF2 CEND1 LRRC8D MYORG HNRNPU CDCA2 TMTC1 CFAP54 GSPT2 MKI67 PRKCB MLLT3 FLRT3 CFAP418 CSPP1 NIPBL PHF21B CA3 | 1.17e-05 | 1370 | 132 | 23 | facebase_RNAseq_e10.5_NeuroEpith_central_2500_K4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | RANBP2 TUT4 TEX9 LRRC8D HNRNPU MKI67 MLLT3 PIBF1 NIPBL ZNF292 | 2.54e-05 | 311 | 132 | 10 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | SART3 RANBP2 PCLO E2F7 TEX9 EPB41L4A HNRNPU CDCA2 PRRC2C ACIN1 MLLT3 PIBF1 NIPBL | 2.82e-05 | 532 | 132 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | SART3 RANBP2 TUT4 RSL1D1 PCLO U2SURP ETF1 TEX9 EPB41L4A POLR1G LRRC8D HNRNPU MKI67 MLLT3 PIBF1 NIPBL PHF21B ZNF292 | 4.15e-05 | 989 | 132 | 18 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | NWD1 TUT4 APOO RSL1D1 STK26 PCLO TEX9 HNRNPU RPRD1B USP38 TET1 MKI67 ZFHX3 CSPP1 NIPBL ATG16L2 ZNF292 DUSP11 | 4.15e-05 | 989 | 132 | 18 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | DevelopingGonad_e11.5_ovary + mesonephros_emap-3226_k-means-cluster#1_top-relative-expression-ranked_1000 | 6.23e-05 | 159 | 132 | 7 | gudmap_developingGonad_e11.5_ovary + mesonephros_k1_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | RAD18 TUT4 APOO ANK2 ATR RSL1D1 E2F7 CEND1 PPA1 TTF1 MYORG HNRNPU CDCA2 TET1 MKI67 ZFHX3 PIBF1 CSPP1 NIPBL ZNF292 | 9.79e-05 | 1257 | 132 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_top-relative-expression-ranked_1000 | RNF32 SDE2 RAD18 ENKUR ATR LARS1 PHTF2 EPB41L4A CDCA2 USP26 EEF1G TET1 DEPDC7 DDX21 SNRPN | 1.28e-04 | 795 | 132 | 15 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_1000 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | NRIP1 RAD18 RBM45 RGS5 STK26 CD2AP DIDO1 ZNF318 CDCA2 KITLG PRRC2C TET1 ACIN1 CSPP1 SNRPN | 1.49e-04 | 806 | 132 | 15 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_1000 | RNF32 SDE2 RAD18 ENKUR LARS1 PHTF2 CDCA2 USP26 TET1 DDX21 SNRPN | 1.53e-04 | 463 | 132 | 11 | gudmap_dev gonad_e11.5_F_PrimGermCell_Oct_k3_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | RAD18 TUT4 APOO ANK2 ATR RSL1D1 E2F7 CEND1 PPA1 TTF1 MYORG HNRNPU CDCA2 TET1 MKI67 ZFHX3 PIBF1 CSPP1 NIPBL PHF21B ZNF292 | 2.59e-04 | 1459 | 132 | 21 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_k-means-cluster#3_top-relative-expression-ranked_500 | 2.64e-04 | 142 | 132 | 6 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#5 | 2.92e-04 | 204 | 132 | 7 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K5 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg2-24ahi.Th, TCRd+ Vg2- CD24+, Thymus, avg-2 | 3.13e-04 | 422 | 132 | 10 | GSM476658_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.47e-04 | 210 | 132 | 7 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k1 | |
| CoexpressionAtlas | dev gonad_e11.5_M_PrimGermCell_Oct_top-relative-expression-ranked_1000 | RNF32 SDE2 RAD18 ENKUR ATR LARS1 PHTF2 TEX9 EPB41L4A CDCA2 USP26 TET1 DDX21 SNRPN | 3.66e-04 | 781 | 132 | 14 | gudmap_dev gonad_e11.5_M_PrimGermCell_Oct_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Olfactory Pit_top-relative-expression-ranked_500_k-means-cluster#4 | 3.68e-04 | 98 | 132 | 5 | Facebase_RNAseq_e10.5_Olfactory Pit_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | NWD1 TUT4 APOO HNRNPU TET1 MKI67 NIPBL ATG16L2 ZNF292 DUSP11 | 3.76e-04 | 432 | 132 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#1_top-relative-expression-ranked_1000 | 3.86e-04 | 99 | 132 | 5 | gudmap_developingGonad_e14.5_ epididymis_1000_k1 | |
| CoexpressionAtlas | dev gonad_e13.5_M_GermCell_Oct_k-means-cluster#2_top-relative-expression-ranked_500 | 4.08e-04 | 56 | 132 | 4 | gudmap_dev gonad_e13.5_M_GermCell_Oct_k2_500 | |
| ToppCell | critical-Epithelial-Ciliated|critical / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 8.58e-09 | 196 | 134 | 9 | 27b855c6e1ae44f16db998cf0e81bd686b9cee7e | |
| ToppCell | critical-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 9.37e-09 | 198 | 134 | 9 | ee2c8385c0bf4ea9f5c9517b52cf131af3fbdd40 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.37e-09 | 198 | 134 | 9 | 44417089b62056269cac38d3134ff209c05b7007 | |
| ToppCell | PBMC-Mild|PBMC / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.37e-09 | 198 | 134 | 9 | 28ef3fc4c17dcb765537b75917f7db78baa522db | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.02e-08 | 200 | 134 | 9 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-08 | 148 | 134 | 8 | d61123f0c811287843d066b932b4a9ff09c07c5b | |
| ToppCell | LPS-antiTNF-Epithelial_airway-Ciliated_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.66e-08 | 148 | 134 | 8 | c8e93b87212f55774223caa385859c566fa1981f | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.35e-07 | 194 | 134 | 8 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | moderate-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.41e-07 | 195 | 134 | 8 | 3486eae5fdb062a75a907b896c9d7b396d2aa195 | |
| ToppCell | moderate-Epithelial-Ciliated|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.41e-07 | 195 | 134 | 8 | e80f5cdf0b18066b3e6c2f5452e58f101c67932c | |
| ToppCell | COVID-19_Mild|World / Disease group, lineage and cell class | 1.52e-07 | 197 | 134 | 8 | 5c33454b10023decd2f5ccda9229b6512659711e | |
| ToppCell | Mild/Remission-B_naive-1|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.65e-07 | 143 | 134 | 7 | bd3f5fbd4e9e4dc414682db5607494f3ce988deb | |
| ToppCell | 3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | 8.86e-07 | 171 | 134 | 7 | 2e9a20f8980b78325c52065a9c14ab3656267c05 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-06 | 176 | 134 | 7 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | droplet-Marrow-nan-3m-Hematologic-hematopoietic_precursor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.16e-06 | 178 | 134 | 7 | 8aef208b6351143562c87715bb11628880abce94 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-06 | 186 | 134 | 7 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.92e-06 | 192 | 134 | 7 | aee6522d25e012231cdb905ce047295cb64d6e82 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.99e-06 | 193 | 134 | 7 | 95f5611dd9583f339b7c9f52bb478af204fb89ad | |
| ToppCell | ASK440-Epithelial-Ciliated|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.99e-06 | 193 | 134 | 7 | a0baa8be6f590b2031fede22be588715ae458e93 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.06e-06 | 194 | 134 | 7 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.13e-06 | 195 | 134 | 7 | 649fd2336e963f6a150d182a53ad5dd838ca80b1 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.13e-06 | 195 | 134 | 7 | 129ad5f4253ecb1a8477cc38773e6e91ea9570b0 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.13e-06 | 195 | 134 | 7 | 3e70ee987d66d450062d5df3d7c733ccc7344470 | |
| ToppCell | Control_saline-Epithelial_airway-airway_epithelial-Ciliated|Control_saline / Treatment groups by lineage, cell group, cell type | 2.13e-06 | 195 | 134 | 7 | 60067b5359174f0d1a8b5748bfc0690762e9e740 | |
| ToppCell | COVID-19-Epithelial-Ciliated_cells|Epithelial / Condition, Lineage and Cell class | 2.20e-06 | 196 | 134 | 7 | de7aa31354b019d7321a8ef965d59ce2e8b89276 | |
| ToppCell | mild_COVID-19_(asymptomatic)|World / disease group, cell group and cell class (v2) | 2.20e-06 | 196 | 134 | 7 | 8cb3dcb3e5732f4bb060c87ca339b8997a1a8cd4 | |
| ToppCell | NS-moderate-d_0-4-Epithelial-Ciliated|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.28e-06 | 197 | 134 | 7 | 71fea4aa6ce96c7693fa94792d08770622873850 | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 2.43e-06 | 199 | 134 | 7 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | (09)_Interm._secr.>cil.-(2)_GFP_FOXI1|(09)_Interm._secr.>cil. / shred by cell type by condition | 2.43e-06 | 199 | 134 | 7 | fc680f85ebd3bab4c72876a19a461b0afb5f51ce | |
| ToppCell | Striatum-Neuronal|Striatum / BrainAtlas - Mouse McCarroll V32 | 2.52e-06 | 200 | 134 | 7 | c888fd487990cad482a4ca47601cdebc0ca3f3ce | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Neuronal-Intermediate|6m / Sample Type, Dataset, Time_group, and Cell type. | 2.52e-06 | 200 | 134 | 7 | 7c261e39ac30b318511373ab7302aa53b8b81b9c | |
| ToppCell | severe-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.52e-06 | 200 | 134 | 7 | f74bdabadca8ad6dae1b6e6812c66325aac50db0 | |
| ToppCell | (08)_Brush+PNEC-(2)_GFP_FOXI1|(08)_Brush+PNEC / shred by cell type by condition | 3.88e-06 | 138 | 134 | 6 | 817e3f639604ea95adae01e8685ffaa2e0aff7a8 | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.52e-06 | 151 | 134 | 6 | 81cf939ed4df9574fbfff265e109cb9f947d7e6e | |
| ToppCell | LPS-IL1RA-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.52e-06 | 151 | 134 | 6 | 9cbcbbc22965a9f0be8364e733d205dd64f2a533 | |
| ToppCell | COVID-19_Mild|World / 5 Neutrophil clusters in COVID-19 patients | 6.77e-06 | 152 | 134 | 6 | 2ff0980dfd8d430cca14649151d856edef115720 | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells-Ciliated|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.30e-06 | 154 | 134 | 6 | 4e3bc24043144143842627cacf6f90dda2228910 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells-Ciliated|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.30e-06 | 154 | 134 | 6 | 9ca71d440c4f87781e6525b8141e7d8d470b6a8e | |
| ToppCell | Control-Epithelial_airway-Ciliated_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.30e-06 | 154 | 134 | 6 | 7556a4b2b062da5ae7ec2bbb66e745e7662db628 | |
| ToppCell | LPS_only-Epithelial_airway-Ciliated_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.30e-06 | 154 | 134 | 6 | 58072ce422d09f2de602580325eaac6c4ec6c136 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.57e-06 | 155 | 134 | 6 | 5f1e2195a6b831e1b636f5cc3a282ca423721822 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_airway-Ciliated_cells-Ciliated|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.57e-06 | 155 | 134 | 6 | 0944429459f642a1bcc56edc1ec28aaecde3e2dc | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 8.15e-06 | 157 | 134 | 6 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | Severe-B_naive-1|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 8.76e-06 | 159 | 134 | 6 | 2881b054bbeb479221ee3c38bbd9b0815b123579 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c12-MKI67-TYROBP|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.05e-05 | 164 | 134 | 6 | 4ef776d1bab4103d42d3a4f22cdfb49e8d2bc5a0 | |
| ToppCell | lung-Ciliated_Epithelia|lung / shred on tissue and cell subclass | 1.16e-05 | 167 | 134 | 6 | 26cf1cfa58ee74794449a87eb19cd896e1ec8892 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_neuroendocrine_cell_(PNEC)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.16e-05 | 167 | 134 | 6 | c87ebfa8c3284ad33579190e148c95bcaf670d17 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.24e-05 | 169 | 134 | 6 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | PND07-28-samps-Epithelial-Epithelial-non_alveolar-Ciliated_cell_of_lung_parenchyma|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 1.46e-05 | 174 | 134 | 6 | f41d05a3703d7092bd3c4a97c15ae13069aaa4ad | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.72e-05 | 179 | 134 | 6 | 5e5f1cdf4aa66868d45b74ba91e20e848a3cbaff | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Pheochromocytoma-Pheochromocytoma-1|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 1.72e-05 | 179 | 134 | 6 | 431e1b29015ec817f778499106d24b19cfc825ae | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.77e-05 | 180 | 134 | 6 | 92fb01b91261b3103454924cde56add337b41844 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 1.89e-05 | 182 | 134 | 6 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 182 | 134 | 6 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | COVID-19_Mild-CD4+_T_activated|COVID-19_Mild / Disease condition and Cell class | 1.89e-05 | 182 | 134 | 6 | 877b6e611626628e709568747512f2827ebb2795 | |
| ToppCell | droplet-Spleen-nan-18m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.89e-05 | 182 | 134 | 6 | eeb5dfa4539e9ca5220f26bc2b65717ddcf13b6c | |
| ToppCell | Ciliated_cells-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.89e-05 | 182 | 134 | 6 | e93968f800bfeb258e4e834fc8bf92d1cb72cd73 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 183 | 134 | 6 | 28cbf909424f3be4491d49832f0aca0386560814 | |
| ToppCell | droplet-Spleen-nan-18m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 183 | 134 | 6 | 3fa608aa6b119869ec3280dc388dfee57160e63a | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 184 | 134 | 6 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 2.07e-05 | 185 | 134 | 6 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | droplet-Liver-LIVER_HEP-30m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 185 | 134 | 6 | bdd2e6cb20294b39a9d856004bf57ba69cf877e2 | |
| ToppCell | NS-critical-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.13e-05 | 186 | 134 | 6 | 76033438426d8f9c72cd6691a7baf92104c9f03d | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.13e-05 | 186 | 134 | 6 | b45cce768e4bf91da194fd9660cab7520dfb15ac | |
| ToppCell | droplet-Bladder-nan|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 187 | 134 | 6 | 663991a8afe652e92363b64bcbd68c14d0307f0e | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 187 | 134 | 6 | 91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.20e-05 | 187 | 134 | 6 | f3397dbc23b6c2f24e2c1ba887d8f9aef3ee01a1 | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-05 | 187 | 134 | 6 | 382db691eb0b3e089e816bed3d6699cc2d4e1bda | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 2.26e-05 | 188 | 134 | 6 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | 10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_neural-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.26e-05 | 188 | 134 | 6 | e239bcdbd210a398a5850cb6fbf171d402f45a4f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c06-NR4A2|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.26e-05 | 188 | 134 | 6 | 939790f133eac9c12d08db6ddb5f08f5107844e3 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-lung_neuroendocrine_cell_(PNEC)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.26e-05 | 188 | 134 | 6 | c4c3b21ab723b0e9beff9ec84f8d68485f771528 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-intestinal_crypt_stem_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.40e-05 | 190 | 134 | 6 | 52c59001a079c76249abbaa3141e9e661b83d9a0 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.40e-05 | 190 | 134 | 6 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25|PBMC_fresh-frozen / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.47e-05 | 191 | 134 | 6 | 1ecd9849d14d5ebf3daf610e83fb50820cafd3ed | |
| ToppCell | Mild/Remission-B_activate-7|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.47e-05 | 191 | 134 | 6 | 382686d62f7b8576c44bb9726a4e10dc26fd348e | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.55e-05 | 192 | 134 | 6 | ef8970e5389bd55c1624cd6dd01a7ca7abaa8950 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.62e-05 | 193 | 134 | 6 | e1b76102f812c433195d1e8811fdd3293a7bc22e | |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.62e-05 | 193 | 134 | 6 | ea345d34440b25f65358a53dc72831998d1c3620 | |
| ToppCell | COVID-19-kidney-CD-PC|kidney / Disease (COVID-19 only), tissue and cell type | 2.62e-05 | 193 | 134 | 6 | 738689d009e4b118d7ce3171a207294b95cbe78b | |
| ToppCell | ASK440-Epithelial-Ciliated|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.70e-05 | 194 | 134 | 6 | c84a7fa94fb06e08aae04db56c8c313b0afde1d7 | |
| ToppCell | LPS-IL1RA-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-05 | 194 | 134 | 6 | 43f92b0533e26633dc94cce554045d641ef8fd76 | |
| ToppCell | Bronchial_Brush-Epithelial-Ciliated_1|Bronchial_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.70e-05 | 194 | 134 | 6 | b4ce60c06568123008b1081d644733cb91c28f51 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocytopoietic_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.70e-05 | 194 | 134 | 6 | 8ef0b71fef5b84cfd04973f891215333e7035d1d | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.70e-05 | 194 | 134 | 6 | 1d39d968730a7e85b6161c1c8a6bd38afe9bcad7 | |
| ToppCell | ASK452-Epithelial-Ciliated|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.70e-05 | 194 | 134 | 6 | 5aeb44657ab6f61b1abf98af28d3397d8e44c1aa | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.78e-05 | 195 | 134 | 6 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.78e-05 | 195 | 134 | 6 | ed5f772c82d4dfd1c8735224446ec9feae3fb8c2 | |
| ToppCell | (1)_T_cells-(1)_T_CD4_naive|(1)_T_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 2.78e-05 | 195 | 134 | 6 | d3fa551bc6f5ee5890af1040415e61ecd5d46201 | |
| ToppCell | normal-na-Lymphocytic_T-T4_naive-male|normal / PBMC cell types (v2) per disease, treatment status, and sex | 2.86e-05 | 196 | 134 | 6 | feb1c768cf66c64b6c892905d2d865946e70812f | |
| ToppCell | Mild/Remission|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.86e-05 | 196 | 134 | 6 | 71603a3b7df40eb3f267345f55e44a812fea7926 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-05 | 197 | 134 | 6 | 22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-05 | 197 | 134 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-05 | 197 | 134 | 6 | 3bbf068d2ad8196fbc85d3f311a7c54c9aece856 | |
| ToppCell | control-Epithelial-Ciliated|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.94e-05 | 197 | 134 | 6 | e453d085182364ca347cbcc9dc995c62c3353016 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.94e-05 | 197 | 134 | 6 | 87db09f341e2b20eb6e1c3e917cb5c960387b3e9 | |
| ToppCell | Tracheal-10x5prime-Epithelial-Epi_airway_ciliated-Deuterosomal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.94e-05 | 197 | 134 | 6 | 6e4a411ef823ce9e16f420e185e21fa19d13af34 | |
| ToppCell | control-Epithelial-Ciliated|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.94e-05 | 197 | 134 | 6 | d4e963c1f82996371bf3d63578ee9fce8e00c5a8 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 3.03e-05 | 198 | 134 | 6 | 61ceb2245b6cb58e308b999a61d218c89dbc615e | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 3.11e-05 | 199 | 134 | 6 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| Disease | tacrolimus measurement | 1.15e-04 | 4 | 130 | 2 | EFO_0008458 | |
| Disease | estrone conjugate measurement | 1.15e-04 | 4 | 130 | 2 | EFO_0007971 | |
| Disease | tauro-beta-muricholate measurement | 1.91e-04 | 5 | 130 | 2 | EFO_0800213 | |
| Disease | glyco-beta-muricholate measurement | 1.91e-04 | 5 | 130 | 2 | EFO_0800569 | |
| Disease | hyperopia | 2.86e-04 | 6 | 130 | 2 | MONDO_0004891 | |
| Disease | dehydroisoandrosterone sulfate DHEA-S measurement | 2.86e-04 | 6 | 130 | 2 | EFO_0021119 | |
| Disease | androstenediol (3beta,17beta) monosulfate (1) measurement | 2.86e-04 | 6 | 130 | 2 | EFO_0800294 | |
| Disease | Colorectal Carcinoma | ANK2 SF3A1 PARP8 GRID1 PTPRN2 MKI67 ACIN1 PRKCB SNRNP200 IL6ST ZNF292 | 2.87e-04 | 702 | 130 | 11 | C0009402 |
| Disease | X-24574 measurement | 3.99e-04 | 7 | 130 | 2 | EFO_0800897 | |
| Disease | testosterone measurement | CYP3A7 DENND4A ANK2 CYP3A4 RGS5 ETF1 ZNF318 POLR1G MSR1 CDCA2 ARID1B MGAT5 PRKCA ZFHX3 LMAN2 | 5.08e-04 | 1275 | 130 | 15 | EFO_0004908 |
| Disease | androstenediol (3beta,17beta) disulfate (1) measurement | 6.80e-04 | 9 | 130 | 2 | EFO_0800278 | |
| Disease | Neurodevelopmental Disorders | 7.76e-04 | 93 | 130 | 4 | C1535926 | |
| Disease | tauopathy (implicated_via_orthology) | 8.47e-04 | 10 | 130 | 2 | DOID:680 (implicated_via_orthology) | |
| Disease | 4-androsten-3alpha,17alpha-diol monosulfate (3) measurement | 8.47e-04 | 10 | 130 | 2 | EFO_0022090 | |
| Disease | 5alpha-androstan-3beta,17alpha-diol disulfate measurement | 8.47e-04 | 10 | 130 | 2 | EFO_0800289 | |
| Disease | Malignant neoplasm of breast | NRIP1 ANK2 CYP3A4 YY2 ARHGEF38 ZNF318 PPA1 CNTN6 EOMES ARID1B MKI67 ELK3 NIPBL | 9.40e-04 | 1074 | 130 | 13 | C0006142 |
| Disease | DNA repair protein RAD51 homolog 4 measurement | 1.03e-03 | 11 | 130 | 2 | EFO_0801531 | |
| Disease | androstenediol (3beta,17beta) monosulfate (2) measurement | 1.03e-03 | 11 | 130 | 2 | EFO_0800295 | |
| Disease | 5alpha-androstan-3beta,17beta-diol monosulfate (2) measurement | 1.24e-03 | 12 | 130 | 2 | EFO_0800291 | |
| Disease | androstenediol (3alpha, 17alpha) monosulfate (3) measurement | 1.46e-03 | 13 | 130 | 2 | EFO_0800293 | |
| Disease | 5alpha-pregnan-3beta,20beta-diol monosulfate (1) measurement | 1.46e-03 | 13 | 130 | 2 | EFO_0800284 | |
| Disease | X-21470 measurement | 1.69e-03 | 14 | 130 | 2 | EFO_0800817 | |
| Disease | Pneumoconiosis | 1.69e-03 | 14 | 130 | 2 | C0032273 | |
| Disease | Bagassosis | 1.69e-03 | 14 | 130 | 2 | C0004681 | |
| Disease | 5alpha-androstan-3alpha,17alpha-diol monosulfate measurement | 1.69e-03 | 14 | 130 | 2 | EFO_0800283 | |
| Disease | alcohol use disorder (implicated_via_orthology) | 1.76e-03 | 195 | 130 | 5 | DOID:1574 (implicated_via_orthology) | |
| Disease | neuroblastoma | 1.76e-03 | 116 | 130 | 4 | EFO_0000621 | |
| Disease | 16a-hydroxy DHEA 3-sulfate measurement | 1.95e-03 | 15 | 130 | 2 | EFO_0800301 | |
| Disease | X-21410 measurement | 2.22e-03 | 16 | 130 | 2 | EFO_0800813 | |
| Disease | andro steroid monosulfate C19H28O6S (1) measurement | 2.22e-03 | 16 | 130 | 2 | EFO_0800305 | |
| Disease | respiratory symptom change measurement, response to placebo | 2.51e-03 | 17 | 130 | 2 | EFO_0008344, EFO_0010068 | |
| Disease | ischemia (biomarker_via_orthology) | 2.81e-03 | 18 | 130 | 2 | DOID:326 (biomarker_via_orthology) | |
| Disease | 5alpha-androstan-3alpha,17beta-diol monosulfate (1) measurement | 2.81e-03 | 18 | 130 | 2 | EFO_0800288 | |
| Disease | metabolonic lactone sulfate measurement | 3.14e-03 | 19 | 130 | 2 | EFO_0800659 | |
| Disease | pulmonary non-tuberculous mycobacterial infection | 3.14e-03 | 19 | 130 | 2 | MONDO_0018469 | |
| Disease | etiocholanolone glucuronide measurement | 3.14e-03 | 19 | 130 | 2 | EFO_0800362 | |
| Disease | dehydroepiandrosterone sulphate measurement | 3.40e-03 | 68 | 130 | 3 | EFO_0007001 | |
| Disease | androsterone glucuronide measurement | 3.47e-03 | 20 | 130 | 2 | EFO_0800317 | |
| Disease | Joubert syndrome 1 | 3.83e-03 | 21 | 130 | 2 | C4551568 | |
| Disease | transferrin glycosylation measurement | 3.83e-03 | 21 | 130 | 2 | EFO_0021537 | |
| Disease | X-24947 measurement | 4.20e-03 | 22 | 130 | 2 | EFO_0800910 | |
| Disease | 5alpha-androstan-3beta,17beta-diol disulfate measurement | 4.20e-03 | 22 | 130 | 2 | EFO_0021115 | |
| Disease | electroencephalogram measurement | 4.31e-03 | 74 | 130 | 3 | EFO_0004357 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KVDFQTVPENPKRKK | 686 | Q9BXU7 | |
| SIEQKLPRKPKTDKF | 131 | Q15361 | |
| SEKKEKAQEEPPAKL | 1196 | Q9UKV3 | |
| KPEPARAKAKLSKFS | 271 | P51826 | |
| IKTKGKEAPFTKFDP | 166 | P07451 | |
| PSPQKLDLDKASKKF | 41 | O95936 | |
| PENKFKTVITNKSKP | 2221 | Q96N23 | |
| DKFSKKLQPEPNSVT | 51 | Q8NAA4 | |
| ESSKKPKENKPLKEE | 231 | P42568 | |
| KLSFEKKKPVQILPE | 551 | Q9NXL2 | |
| TKQPDIKNPKLTKDH | 386 | Q9NZU0 | |
| EKKFNALKVPVPEDK | 71 | O75947 | |
| GKIKKKEVFPFPEVS | 46 | Q9H845 | |
| LTKPSKKEAPAEKQQ | 36 | Q8N111 | |
| LEEPNLDKKPSKLKS | 71 | Q96NL8 | |
| KTEQKEPKPLEKSVS | 146 | Q9UKB3 | |
| AADPKEKPKQASKFD | 1841 | Q8NFD5 | |
| VQINELDKDFPKPKK | 326 | Q9Y5K6 | |
| VPTKVFGKDKKPTFE | 111 | Q96QD5 | |
| IKPFPKITDTKKTED | 426 | Q8N865 | |
| KSKFKAKEPRSPVIT | 336 | Q6P387 | |
| AKASPQDPLKNFKKA | 1506 | Q149M9 | |
| PEGFLQAKKNKLPSK | 711 | Q7Z401 | |
| EEKAKADTLKLPPTF | 2721 | P49792 | |
| KKKAPAETPVKERLF | 381 | Q8IUH3 | |
| KENKSKFSPQKEASP | 151 | Q9NS91 | |
| KFSPQKEASPAAKTK | 156 | Q9NS91 | |
| ANEKSEKPPENQKKL | 51 | Q8N6M8 | |
| SKSKLKFLPPQAEQE | 596 | Q92932 | |
| ENKADEAKPKSKLPV | 3336 | Q01484 | |
| SPLKTKAKVTEPKEF | 176 | D6REC4 | |
| KAKVTEPKEFNLTAP | 181 | D6REC4 | |
| KNLEKQLEAPAKKPA | 676 | Q8IYY4 | |
| APKSSKTELFKEPNA | 436 | Q8N3A8 | |
| KIEPSVNFLKSPKDN | 291 | Q12907 | |
| LAKDILVPSFDPKNK | 686 | Q09328 | |
| KKDSPPKNSVKVDEL | 26 | Q9BUR5 | |
| LFPPKSINTLKDIKD | 296 | Q8TCX1 | |
| VSTFLKKKQETKRPP | 1146 | Q8IY21 | |
| KSDDPVVPSLFKQKT | 466 | Q5H9U9 | |
| PEKFLPERFSKKNKD | 411 | P08684 | |
| LTPDKKENLSKNKAP | 781 | Q5T0W9 | |
| KEKENLKPAKAQLPF | 76 | A6NNH2 | |
| VPFLKKVGFSPKKDI | 371 | Q8IYD1 | |
| KKPQKSKPGVFSFLD | 526 | P42262 | |
| EKDKASALQEKKPLP | 1201 | Q9Y6V0 | |
| EKSTEPKSQRNKKPI | 201 | Q1MSJ5 | |
| EESKKALPPEKKQNT | 671 | Q00839 | |
| EDKSRSSLKPIKNKP | 1021 | Q6KC79 | |
| KPKQRKSIFDPNTFK | 966 | Q8TDM6 | |
| KSKVKDQKPDTNLPD | 191 | P48552 | |
| RPTKFVVSPKNLKKD | 181 | Q96QE4 | |
| KPNLTTDTKDKEYKP | 196 | Q9UGL1 | |
| IPDPKSESKQKTKTI | 201 | P05771 | |
| SIKAFKESPKQILDP | 2521 | P46013 | |
| PKNSPSLQEKLKSFK | 36 | P21757 | |
| DPKAEEKSPKKQKVT | 21 | Q9NR20 | |
| KKKIPSPVKLAFIDN | 771 | Q13535 | |
| KKPFPEDLKSLDLFK | 701 | P40189 | |
| PIKNEPIDLSKQKKF | 46 | Q96AV8 | |
| KVPLQKSFEKKLAPE | 101 | O75319 | |
| KPSNTFIKEIPTKKE | 856 | Q5T0N1 | |
| KEKSKKPVRFLPQLS | 11 | Q8WXX0 | |
| EAPKAIKPTSKEFRK | 11 | Q9BTC0 | |
| AEAQSLKPSKAEKPL | 326 | P27544 | |
| SAPDFSKSPVKKKSF | 406 | Q9UQ52 | |
| TKADKDIKNPIQPSF | 106 | Q9BSJ5 | |
| LQNPPDAFKAIKTEK | 151 | P41970 | |
| HSKEKTLPPKKNFDR | 66 | Q8TC29 | |
| FEKALEKKPKNPEFT | 161 | P09913 | |
| ATKDPLNPIKQDVKK | 61 | Q15181 | |
| IPKAKNKSESENEPK | 691 | Q69YH5 | |
| KKPEEKISIFSLFAP | 546 | Q9ULK0 | |
| FAETQPKKDTPRKEK | 221 | P26641 | |
| KTRADPKTFALPKKQ | 2746 | Q8NDH2 | |
| PEKFLPERFSKKNKD | 411 | P24462 | |
| VFPKAKQVKKKAEPS | 51 | Q9NR30 | |
| KAKKKEEPSQNDISP | 76 | Q9NR30 | |
| IAPSPVKSFKKAKNE | 386 | Q9HCS5 | |
| QIDPALFAKPLKGKK | 436 | Q6IQ49 | |
| EPPSKQKEKAASLKR | 676 | Q15020 | |
| PSNASEKEPTQKKKL | 6 | O75995 | |
| GPDESKQKFVLKTPK | 46 | P12081 | |
| ALPNQEAKKEKKDPT | 121 | Q7L1W4 | |
| PKSKAKAIPVSRFKE | 76 | Q5JY77 | |
| KKKTAVKRDDPNPVF | 336 | Q8IV01 | |
| FSSKFQKLETFKPPK | 226 | Q68CQ4 | |
| QKLETFKPPKDIDLK | 231 | Q68CQ4 | |
| IPKDKDGKPKQFAFV | 41 | Q9Y580 | |
| NKPKKTAHVKPDLID | 76 | Q8N3S3 | |
| PPKATEEKKSLKRTF | 136 | Q9NQG5 | |
| DEFRKIKPKNAKQPE | 46 | P63162 | |
| KKFKLQSFEPKTPTV | 1636 | A0AVI2 | |
| IPDPKNESKQKTKTI | 201 | P17252 | |
| NEKPEKPAKTQKTSL | 41 | O15539 | |
| FTTVRKKPDPKKVQN | 326 | Q9P289 | |
| KEAPFPKTQIAKEKL | 641 | Q9P2J5 | |
| PKKPKEKVDALSQFD | 1636 | Q9Y520 | |
| DLEPQAAPTSTKKKK | 411 | O15446 | |
| KTVPPTDAKLRKKFF | 211 | Q9H0A6 | |
| KNKTVKDLKSEPNPL | 66 | P0DKX4 | |
| KDLKKSFKSPEPRLF | 121 | P21583 | |
| PPKGLFSKLKKEAEN | 221 | Q15459 | |
| PKAVKAPESLEKIKF | 431 | Q8N1H7 | |
| KEKQESELKLKSFAP | 111 | Q5VX52 | |
| FPSLKELISKFEKPN | 76 | O14796 | |
| DSKKNEPIFKVAPSK | 746 | O15042 | |
| PQREKKPKVLKADFD | 646 | Q8NFU7 | |
| KPKVLKADFDNKPVN | 651 | Q8NFU7 | |
| KPPDVDLKKFFTDRK | 211 | O14967 | |
| DTPLSPEELKEKQKK | 936 | Q9Y2H5 | |
| KPKDPKVISELFFTK | 781 | Q8IUR5 | |
| SEKKNPPRFTLKKLV | 431 | Q99973 | |
| FTDFSLPPSRKQKKK | 151 | Q9UHK0 | |
| ATKKKKEDRPPTQEN | 261 | Q96EK2 | |
| KKPEAKFFTTPSKSV | 456 | O76021 | |
| KTSKFPENPRESKQL | 426 | Q76KD6 | |
| NPAAEEDLKKVKLPK | 941 | Q15413 | |
| IETKVKPSSKFSLPK | 921 | Q9BXM0 | |
| DPKQLAEFTKVKPKR | 231 | O15391 | |
| KEDLPKSSEKAIQPK | 131 | Q86VQ3 | |
| DNIFTPKPTLFTKKE | 731 | Q8WXW3 | |
| EKKRKKPVSQSLEFP | 2091 | O60281 | |
| DDLFQSAKPKPAKKT | 1161 | Q9Y4E1 | |
| KLEPSKPNFSIKEAK | 606 | Q8N841 | |
| AIKDFPKPSEEKIKL | 401 | Q8NB14 | |
| PEEVVKKIEKKNFPF | 1136 | O75643 | |
| DDDLFQSAKPKPAKK | 1181 | Q641Q2 | |
| ASKKPFSIAEELIKP | 841 | O95789 | |
| FPAELALKKSKPESN | 311 | Q8WWH5 | |
| FQVFLPKGSKEKSKP | 166 | Q8TCF1 | |
| AFEDEKPPKKSLLSK | 36 | Q01831 | |
| CKAKKFPNSPVKAEK | 96 | Q5TAX3 | |
| DTPSKFLSKDKLFKP | 821 | Q92547 | |
| SKVNNEKFRTKSPKP | 1026 | Q5VUA4 | |
| SETKPKTKNIDPVNK | 101 | Q8N6V9 | |
| KDKEPLVSFLEPKNK | 331 | Q15911 | |
| SKLKKTETQEKNPLP | 16 | P62328 | |
| LQKSFPKEKDDLSPQ | 1126 | Q5THJ4 | |
| KEKKVNIDFEPFKPI | 106 | P62495 | |
| DNFSPAKPKPSKDLK | 41 | Q6NSJ0 | |
| KKPVSAFSKKPRSVE | 6 | Q14896 |